LC4 Consulting is a boutique agency fully focusing on supporting teams with new products in early development stage, including business development programs. We are offering a breath of experience in a wide range of immunotherapies, auto-immune compounds and biologics in the cancer settings, e.g. monoclonal antibodies, Antibody Drug Conjugates (ADC), and cell based cancer vaccines.
Guidance on the SOP for commercialization of early compounds and the required deliverables per clinical development stage (Ph1-2-3).
A systematic strategic analysis of the disease landscape provides the foundation for defining the commercial opportunity and risks in a new therapeutic area.
The Viability Assessment, an interactive work stream with the multi-disciplinary product team, drives the cross-functional alignment on defining the Target Product Profile.
A key list of questions guides the team to maximize the value of the program and improving the optimal pricing and reimbursement of the program.
Development of the cross-functional recommendations for improving the differentiation strategy of your product, increasing the value proposition, and integrating with the Franchise plans.
Capital budgeting prioritization thru defining the profitability of a project by analyzing multiple NPV scenarios.